Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes
Author:
Funder
Goldgrabber Family
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Link
https://link.springer.com/content/pdf/10.1007/s10620-022-07716-0.pdf
Reference29 articles.
1. Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn’s disease in population-based cohorts. Inflamm. Bowel Dis. 2011;17:471–478. https://doi.org/10.1002/ibd.21417.
2. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am. J. Gastroenterol. 2019;114:384–413. https://doi.org/10.14309/ajg.0000000000000152.
3. Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses—Part I. Inflamm. Bowel Dis. 2018;24:742–751. https://doi.org/10.1093/ibd/izx100.
4. O’Shea JJ. Targeting the Jak/STAT pathway for immunosuppression. Ann. Rheum. Dis. 2004;63:67–71. https://doi.org/10.1136/ard.2004.028290.
5. Sandborn WJ, Su C, Sands BE et al. Tofacitinib as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 2017. https://doi.org/10.1056/NEJMoa1606910.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Beyond the Gut: A Systematic Review and Meta-analysis of Advanced Therapies for Inflammatory Bowel Disease-associated Extraintestinal Manifestations;Journal of Crohn's and Colitis;2024-01-08
2. Tofacitinib real-world experience in ulcerative colitis in Finland (FinTofUC): a retrospective non-interventional multicenter patient chart data study;Scandinavian Journal of Gastroenterology;2023-12-29
3. Tofacitinib In Chronic Inflammatory Pouch Diseases. A Systematic Review;Journal of Crohn's and Colitis;2023-12-12
4. Histological healing induced by tofacitinib in ulcerative colitis: A multicentre study;Digestive and Liver Disease;2023-12
5. Real-World Experience With Tofacitinib Dose De-Escalation in Patients With Moderate and Severe Ulcerative Colitis;Clinical Gastroenterology and Hepatology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3